Non-negative matrix factorisation improves Centiloid robustness in longitudinal studies.
Aβ Imaging
Centiloid
Journal
NeuroImage
ISSN: 1095-9572
Titre abrégé: Neuroimage
Pays: United States
ID NLM: 9215515
Informations de publication
Date de publication:
01 02 2021
01 02 2021
Historique:
received:
21
06
2020
revised:
12
10
2020
accepted:
17
11
2020
pubmed:
29
11
2020
medline:
2
3
2021
entrez:
28
11
2020
Statut:
ppublish
Résumé
Centiloid was introduced to harmonise β-Amyloid (Aβ) PET quantification across different tracers, scanners and analysis techniques. Unfortunately, Centiloid still suffers from some quantification disparities in longitudinal analysis when normalising data from different tracers or scanners. In this work, we aim to reduce this variability using a different analysis technique applied to the existing calibration data. All PET images from the Centiloid calibration dataset, along with 3762 PET images from the AIBL study were analysed using the recommended SPM pipeline. The PET images were SUVR normalised using the whole cerebellum. All SUVR normalised PiB images from the calibration dataset were decomposed using non-negative matrix factorisation (NMF). The NMF coefficients related to the first component were strongly correlated with global SUVR and were subsequently used as a surrogate for Aβ retention. For each tracer of the calibration dataset, the components of the NMF were computed in a way such that the coefficients of the first component would match those of the corresponding PiB. Given the strong correlations between the SUVR and the NMF coefficients on the calibration dataset, all PET images from AIBL were subsequently decomposed using the computed NMF, and their coefficients transformed into Centiloids. Using the AIBL data, the correlation between the standard Centiloid and the novel NMF-based Centiloid was high in each tracer. The NMF-based Centiloids showed a reduction of outliers, and improved longitudinal consistency. Furthermore, it removed the effects of switching tracers from the longitudinal variance of the Centiloid measure, when assessed using a linear mixed effects model. We here propose a novel image driven method to perform the Centiloid quantification. The methods is highly correlated with standard Centiloids while improving the longitudinal reliability when switching tracers. Implementation of this method across multiple studies may lend to more robust and comparable data for future research.
Sections du résumé
BACKGROUND
Centiloid was introduced to harmonise β-Amyloid (Aβ) PET quantification across different tracers, scanners and analysis techniques. Unfortunately, Centiloid still suffers from some quantification disparities in longitudinal analysis when normalising data from different tracers or scanners. In this work, we aim to reduce this variability using a different analysis technique applied to the existing calibration data.
METHOD
All PET images from the Centiloid calibration dataset, along with 3762 PET images from the AIBL study were analysed using the recommended SPM pipeline. The PET images were SUVR normalised using the whole cerebellum. All SUVR normalised PiB images from the calibration dataset were decomposed using non-negative matrix factorisation (NMF). The NMF coefficients related to the first component were strongly correlated with global SUVR and were subsequently used as a surrogate for Aβ retention. For each tracer of the calibration dataset, the components of the NMF were computed in a way such that the coefficients of the first component would match those of the corresponding PiB. Given the strong correlations between the SUVR and the NMF coefficients on the calibration dataset, all PET images from AIBL were subsequently decomposed using the computed NMF, and their coefficients transformed into Centiloids.
RESULTS
Using the AIBL data, the correlation between the standard Centiloid and the novel NMF-based Centiloid was high in each tracer. The NMF-based Centiloids showed a reduction of outliers, and improved longitudinal consistency. Furthermore, it removed the effects of switching tracers from the longitudinal variance of the Centiloid measure, when assessed using a linear mixed effects model.
CONCLUSION
We here propose a novel image driven method to perform the Centiloid quantification. The methods is highly correlated with standard Centiloids while improving the longitudinal reliability when switching tracers. Implementation of this method across multiple studies may lend to more robust and comparable data for future research.
Identifiants
pubmed: 33248259
pii: S1053-8119(20)31078-8
doi: 10.1016/j.neuroimage.2020.117593
pmc: PMC8049633
mid: NIHMS1666842
pii:
doi:
Substances chimiques
Amyloid beta-Peptides
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
117593Subventions
Organisme : NIA NIH HHS
ID : R01 AG058676
Pays : United States
Informations de copyright
Copyright © 2020. Published by Elsevier Inc.
Références
Lancet Neurol. 2013 Apr;12(4):357-67
pubmed: 23477989
J Nucl Med. 2019 Apr;60(4):536-540
pubmed: 30190305
Neuroimage. 2008 Nov 15;43(3):430-9
pubmed: 18789389
J Nucl Med. 2018 Jun 14;60(2):285-291
pubmed: 29903930
Neuroimage. 2009 May 15;46(1):154-9
pubmed: 19457369
Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):2053-2059
pubmed: 28643043
Eur J Nucl Med Mol Imaging. 2020 Jul;47(8):1938-1948
pubmed: 31834446
Alzheimers Dement (Amst). 2019 Feb 22;11:180-190
pubmed: 30847382
Nature. 1999 Oct 21;401(6755):788-91
pubmed: 10548103
Alzheimers Dement. 2015 Jan;11(1):1-15.e1-4
pubmed: 25443857
Med Image Comput Comput Assist Interv. 2008;11(Pt 1):442-9
pubmed: 18979777
Alzheimers Res Ther. 2020 Mar 4;12(1):22
pubmed: 32131891
EJNMMI Res. 2018 Dec 5;8(1):107
pubmed: 30519791
Eur J Nucl Med Mol Imaging. 2017 Aug;44(Suppl 1):17-31
pubmed: 28623376
Eur J Nucl Med Mol Imaging. 2020 Feb;47(2):319-331
pubmed: 31863136
J Nucl Med. 2018 May;59(5):822-827
pubmed: 29146694
J Nucl Med. 2015 Apr;56(4):560-6
pubmed: 25745091
J Nucl Med. 2015 Apr;56(4):567-74
pubmed: 25745095
Int Psychogeriatr. 2009 Aug;21(4):672-87
pubmed: 19470201
J Nucl Med. 2016 Aug;57(8):1233-7
pubmed: 26912446